We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group (CME) Q4 Earnings and Revenues Beat Estimates
Read MoreHide Full Article
CME Group Inc. (CME - Free Report) reported fourth-quarter 2020 adjusted earnings per share of $1.39, which beat the Zacks Consensus Estimate by 3%. The bottom line decreased 8.6% year over year due to lower clearing and transaction fees and market data and information services. Average daily volume decreased in three out of the six products lines.
Nonetheless, the company witnessed strong, double-digit, year-over-year growth in the fourth quarter across its Equity Index and Agricultural businesses.
Performance in Detail
CME Group’s revenues of $1.1 billion decreased 3.5% year over year. The year-over-year decrease was primarily due to lower clearing and transaction fees (down 6.4% year over year) and market data and information services (down 3.5% year over year). The top line however beat the Zacks Consensus Estimate by 0.3%.
Total expenses increased 3.2% year over year to $583.5 million during the reported quarter, attributable to higher professional fees and outside services and licensing and other fee agreements
Operating income decreased 10.1% from the prior-year quarter to $515 million.
Average daily volume decreased 3.8% year over year to 16.2 million contracts in the quarter. Average rate per contract decreased 2.5%.
Adjusted earnings of $6.72 per share declined 1.2% year over year but topped the consensus estimate of $6.69.
Operating revenues of $4.9 billion for 2020 increased 0.3% year over year and marginally beat the consensus estimate.
The company achieved record international volume during 2020.
Financial Update
As of Dec 31, 2020, CME Group had $1.6 billion of cash and marketable securities, up 5.3% from 2019 end. As of Dec 31, 2019, long-term debt of $3.4 billion decreased 8% from 2019 end.
As of Dec 31, 2020, the company had total equity worth $26.3 billion, up 0.7% from 2019 end.
Capital Deployment
CME Group has returned about $15.3 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.
Performance of Other Securities Exchange Industry Players
Fourth-quarter earnings of Nasdaq (NDAQ - Free Report) , Intercontinental Exchange (ICE - Free Report) and MarketAxess Holdings (MKTX - Free Report) beat the respective Zacks Consensus Estimate.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.9% per year.
These 7 were selected because of their superior potential for immediate breakout.
Image: Bigstock
CME Group (CME) Q4 Earnings and Revenues Beat Estimates
CME Group Inc. (CME - Free Report) reported fourth-quarter 2020 adjusted earnings per share of $1.39, which beat the Zacks Consensus Estimate by 3%. The bottom line decreased 8.6% year over year due to lower clearing and transaction fees and market data and information services. Average daily volume decreased in three out of the six products lines.
Nonetheless, the company witnessed strong, double-digit, year-over-year growth in the fourth quarter across its Equity Index and Agricultural businesses.
Performance in Detail
CME Group’s revenues of $1.1 billion decreased 3.5% year over year. The year-over-year decrease was primarily due to lower clearing and transaction fees (down 6.4% year over year) and market data and information services (down 3.5% year over year). The top line however beat the Zacks Consensus Estimate by 0.3%.
Total expenses increased 3.2% year over year to $583.5 million during the reported quarter, attributable to higher professional fees and outside services and licensing and other fee agreements
Operating income decreased 10.1% from the prior-year quarter to $515 million.
Average daily volume decreased 3.8% year over year to 16.2 million contracts in the quarter. Average rate per contract decreased 2.5%.
CME Group Inc. Price, Consensus and EPS Surprise
CME Group Inc. price-consensus-eps-surprise-chart | CME Group Inc. Quote
Full-Year Highlights
Adjusted earnings of $6.72 per share declined 1.2% year over year but topped the consensus estimate of $6.69.
Operating revenues of $4.9 billion for 2020 increased 0.3% year over year and marginally beat the consensus estimate.
The company achieved record international volume during 2020.
Financial Update
As of Dec 31, 2020, CME Group had $1.6 billion of cash and marketable securities, up 5.3% from 2019 end. As of Dec 31, 2019, long-term debt of $3.4 billion decreased 8% from 2019 end.
As of Dec 31, 2020, the company had total equity worth $26.3 billion, up 0.7% from 2019 end.
Capital Deployment
CME Group has returned about $15.3 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.
Zacks Rank
CME Group currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Securities Exchange Industry Players
Fourth-quarter earnings of Nasdaq (NDAQ - Free Report) , Intercontinental Exchange (ICE - Free Report) and MarketAxess Holdings (MKTX - Free Report) beat the respective Zacks Consensus Estimate.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.9% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>